Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow-to-Debt Ratio
Pacific Shuanglin Bio pharmacy Co Ltd cash flow-to-debt ratio. Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥70.28 Million could theoretically repay 0% of its total liabilities (CN¥1.55 Billion) in one year. Check Pacific Shuanglin Bio pharmacy Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
Cash flow-to-debt ratio of Pacific Shuanglin Bio pharmacy Co Ltd from 1998 to 2025. Historical debt coverage capacity for Pacific Shuanglin Bio pharmacy Co Ltd across 28 annual periods. Check 000403 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Pacific Shuanglin Bio pharmacy Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Pacific Shuanglin Bio pharmacy Co Ltd. For the full cash flow conversion analysis, see Pacific Shuanglin Bio pharmacy Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | CN¥-215.99 Million | CN¥1.39 Billion | ▼ -164.4% |
| 2024 | 0.24x | CN¥321.79 Million | CN¥1.33 Billion | ▼ -56.9% |
| 2023 | 0.56x | CN¥679.01 Million | CN¥1.21 Billion | ▲ +20.2% |
| 2022 | 0.47x | CN¥524.22 Million | CN¥1.12 Billion | ▼ -12.9% |
| 2021 | 0.54x | CN¥408.22 Million | CN¥760.07 Million | ▲ +89.0% |
| 2020 | 0.28x | CN¥194.84 Million | CN¥685.71 Million | ▼ -30.0% |
| 2019 | 0.41x | CN¥190.84 Million | CN¥470.04 Million | ▲ +143.0% |
| 2018 | 0.17x | CN¥116.63 Million | CN¥698.08 Million | ▲ +454.4% |
| 2017 | -0.05x | CN¥-35.91 Million | CN¥761.70 Million | ▼ -152.5% |
| 2016 | 0.09x | CN¥62.49 Million | CN¥696.41 Million | ▼ -5.6% |
| 2015 | 0.10x | CN¥70.31 Million | CN¥739.82 Million | ▼ -9.3% |
| 2014 | 0.10x | CN¥77.04 Million | CN¥735.16 Million | ▼ -3.8% |
| 2013 | 0.11x | CN¥91.01 Million | CN¥835.47 Million | ▼ -31.0% |
| 2012 | 0.16x | CN¥123.24 Million | CN¥780.27 Million | ▼ -17.7% |
| 2011 | 0.19x | CN¥130.14 Million | CN¥678.06 Million | ▲ +1165.7% |
| 2010 | 0.02x | CN¥9.88 Million | CN¥651.42 Million | ▼ -84.9% |
| 2009 | 0.10x | CN¥111.86 Million | CN¥1.11 Billion | ▲ +39.1% |
| 2008 | 0.07x | CN¥74.90 Million | CN¥1.04 Billion | ▲ +25.3% |
| 2007 | 0.06x | CN¥95.03 Million | CN¥1.65 Billion | ▲ +1058.2% |
| 2006 | -0.01x | CN¥-10.42 Million | CN¥1.73 Billion | ▼ -124.1% |
| 2005 | 0.02x | CN¥49.06 Million | CN¥1.97 Billion | ▲ +128.6% |
| 2004 | -0.09x | CN¥-131.73 Million | CN¥1.51 Billion | ▼ -146.5% |
| 2003 | -0.04x | CN¥-49.47 Million | CN¥1.40 Billion | ▼ -117.0% |
| 2002 | 0.21x | CN¥159.18 Million | CN¥765.52 Million | ▲ +29.1% |
| 2001 | 0.16x | CN¥111.28 Million | CN¥690.82 Million | ▲ +241.0% |
| 2000 | 0.05x | CN¥27.36 Million | CN¥579.29 Million | ▲ +198.0% |
| 1999 | -0.05x | CN¥-23.08 Million | CN¥478.92 Million | ▼ -424.9% |
| 1998 | -0.01x | CN¥-2.65 Million | CN¥288.28 Million | — |